Neoadjuvant chemoradiotherapy
Neoadjuvant chemoradiotherapy
Latest Posts
-
CCT5 and ELF1: Key Biomarkers for Predicting Neoadjuvant Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
Researchers identified CCT5 and ELF1 as significant biomarkers for determining treatment response and prognosis in locally advanced rectal cancer (LARC) patients undergoing neoadjuvant chemoradiotherapy (NCRT). Their study showed that high expression levels of these genes were associated…
You must be logged in to post a comment.